Page 1 in Annual Report 2006

Annual Report 2006 Active Biotech develops innovative drugs that regulate the body’s own immune defense. We focus on cancer and inflammatory diseases where there is an extensive medical need for new and more efficient forms of treatment. The majority of our projects are in clinical development.

  Page 2 - Contents Active Biotech in brief 3 Comments from the CEO 4 Directors’ report  
Archive:
Annual Report 2000
Annual Report 2001
Annual Report 2002
Annual Report 2003
Annual Report 2004
Annual Report 2005
Annual Report 2007
Annual Report 2008
Annual Report 2009
Annual Report 2010
Annual Report 2011
Annual Report 2012
To read this myPaper publication you need to have JavaScript activated in your web browser. You also need to have at least Flash Version 6 installed.